January 10, 2023
Life Sciences
  • Moderna Inc. said it may price its COVID-19 vaccine between $110 and $130 per dose in the United States when commercial distribution begins. The price is similar to the price Pfizer Inc. is considering for its shot developed with BioNTech SE. While the price range is significantly more than Moderna’s contracted rate with the federal government of about $26 per dose, Chief Executive Stephane Bancel said it’s “consistent with the value.” (Article here)